Assistant Professor of Neurology at the University of Alberta
Con to the question "Should Marijuana Be a Medical Option?"
"There's not been a randomized, controlled trial demonstrating that marijuana or any cannabinoid is any more effective in controlled seizures than a placebo. It's terribly complicated from a physician's standpoint, and somewhat frustrating. We have a product that has been legitimized without any evidence of efficacy."
"Medicinal Marijuana on Trial," New York Times, Mar. 29, 2005
Key Experts Physicians [Physicians are the "key experts" in the medical marijuana debate because the issue is thought by many to be ultimately based on the medical value and risks of marijuana, and Physicians, with their training and clinical work, should (at least in theory) have the best knowledge of marijuana's medical value and risks.] [Note: Key Experts definition varies by sites that have this designation.]
Involvement and Affiliations:
Assistant Professor of Neurology, University of Alberta
Assistant Adjunct Professor, Biomedical Engineering
Director, Comprehensive Adult Epilepsy Program, University of Alberta
Fellow of the Royal College of Physicians (Canada)
Cowritten with J Hamm, NL Ashworth, and D Quigley, "Marijuana Use in Epilepsy: Prevalence in Patients of a Tertiary Care Epilepsy Centre," Neurology, 2004
Cowritten with I. Merlet, W. Boling, and J. Gotman, "Relationships Between the Epileptic Focus and Hand Area in Central Epilepsy: Combining Dipole Models and Anatomical Landmarks," Journal of Neurosurgery, 2000
Cowritten with J. Gotman, "Correlation of High Frequency Oscillations with the Sleep-Wake Cycle and Cognitive Activity in Humans," Neuroscience, 1999
Cowritten with J. Gotman, L.F. Quesney, F. Dubeau, and A. Olivier, "Intracranial EEG with Very Low Frequency Activity Fails to Demonstrate an Advantage Over Conventional Recordings," Epilepsia, 1999